You are here: Industry Insights > UK

News List

Cancer research in the UK faces ‘perfect storm’ of funding cuts pharmatimes
April 01, 2021
The Institute of Cancer Research, London (ICR) has made an appeal to Prime Minister Boris Johnson after identifying a ‘perfect storm’ of funding cuts that could impact cancer research in the UK.
92 per cent decrease in UK COVID-19 cases since Jan: GlobalData expresspharma
March 22, 2021
The ending of the national lockdown and the reopening of schools and non-essential industries in April will be a true test of the effectiveness of the vaccinations in limiting the spread of the virus.
UK approval for Daiichi Sankyo’s cholesterol-lowering treatments pharmatimes
March 18, 2021
Daiichi Sankyo’s cholesterol-lowering drugs Nilemdo and Nustendi have been approved by the UK National Institute for Health and Care Excellence (NICE) for use on the NHS.
The UK best among countries dealing with COVID-19 in Europe: Poll pharmaceutical-technology
March 18, 2021
Europe is facing the worst of the COVID-19 pandemic with a higher death rate, sluggish vaccine rollouts, and more virulent variants of the coronavirus.
UK denies EU accusations of Covid-19 vaccine export bans pharmaceutical-technology
March 11, 2021
The UK and the European Union (EU) are embroiled in a public diplomatic row about Covid-19 vaccine exports.
Chancellor pledges an extra £1.65bn for UK’s COVID-19 vaccination roll-out pharmatimes
March 05, 2021
Chancellor Rishi Sunak has unveiled the government’s spending plans for 2021, with much focus given to boosting the economy as COVID-19 restrictions are expected to ease later in the year.
UK to receive 10 million AstraZeneca Covid vaccine doses from India: Report expresspharma
March 03, 2021
The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government.
UK government extends contract with Wockhardt to fill-finish COVID-19 vaccines expresspharma
February 25, 2021
This expands the original agreement from 18 to 24 months i.e., until August 2022 and the manufacturing will continue to be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.
Rentschler Biopharma to build cell and gene therapy manufacturing capabilities in the UK pharmatimes
February 24, 2021
Rentschler Biopharma, a German contract development and manufacturing organisation (CDMO), will build new cell and gene therapy capabilities at a Cell and Gene Therapy (CGT) Catapult site in Stevenage, UK.
UK sees a 20% growth in the number of advanced therapy trials, report finds pharmatimes
February 24, 2021
The UK has had a 20% growth in the number of advanced therapy medicinal product (ATMP) clinical trials, according to a new report from the Cell and Gene Therapy Catapult (CGT Catapult).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page